Sioud Mouldy
The Norwegian Radium Hospital, Department of Immunology, Molecular Medicine Group, Montebello N-0310 Oslo, Norway.
Trends Mol Med. 2006 Apr;12(4):167-76. doi: 10.1016/j.molmed.2006.02.004. Epub 2006 Mar 10.
Toll-like receptors (TLRs) have an important role in innate immunity in mammals by recognizing conserved microbial components that are known as pathogen-associated molecular patterns (PAMPs). Although the majority of these receptors sense pathogen components on the cell surface, a subset of them (TLR3, TLR7, TLR8 and TLR9) senses viral and bacterial nucleic acids in endosomal compartments. Of considerable interest is the recent finding that TLR7 and TLR8 can also recognize small interfering RNA (siRNA), which is the main effector in RNA interference. This immune activation by siRNAs can be abrogated by the 2'-ribose modification of uridines. Here, we discuss the recent developments that have expanded the understanding of self-non-self discrimination of RNAs by the innate immune system, and consider future directions for therapeutic applications of these findings.
Toll样受体(TLRs)通过识别被称为病原体相关分子模式(PAMPs)的保守微生物成分,在哺乳动物的固有免疫中发挥重要作用。尽管这些受体中的大多数在细胞表面感知病原体成分,但其中一部分(TLR3、TLR7、TLR8和TLR9)在内体区室中感知病毒和细菌核酸。最近有一个发现引起了人们极大的兴趣,即TLR7和TLR8也能识别小干扰RNA(siRNA),而siRNA是RNA干扰的主要效应分子。尿苷的2'-核糖修饰可以消除siRNAs的这种免疫激活作用。在这里,我们讨论了最近的进展,这些进展扩展了对固有免疫系统对RNA自我与非自我识别的理解,并考虑了这些发现的治疗应用的未来方向。